Home Cart Sign in  
Chemical Structure| 6956-96-3 Chemical Structure| 6956-96-3

Structure of DMNQ
CAS No.: 6956-96-3

Chemical Structure| 6956-96-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DMNQ is a 1,4-naphthoquinone with redox cycling property. It increases the formation of superoxide and hydrogen peroxide in cells.

Synonyms: NSC 69355

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DMNQ

CAS No. :6956-96-3
Formula : C12H10O4
M.W : 218.21
SMILES Code : O=C1C(OC)=C(OC)C(C2=CC=CC=C21)=O
Synonyms :
NSC 69355
MDL No. :MFCD00184331
InChI Key :ZEGDFCCYTFPECB-UHFFFAOYSA-N
Pubchem ID :3136

Safety of DMNQ

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P362-P403+P233-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human monocytes 0.05, 0.1, 0.2, 1, and 5 μM 1 hour To investigate the effect of DMNQ on the bioenergetic profiles of monocytes. DMNQ decreased ATP-linked respiration, maximal respiration, and reserve capacity, and increased proton leak and non-mitochondrial respiration. PMC4712317
Bovine aortic endothelial cells (BAEC) 20 μM 4 hours To examine the effects of DMNQ alone or in combination with CysNO on cytotoxicity, S-nitrosothiol levels, NADH/NAD+ levels, and mitochondrial function in BAEC. Results showed that DMNQ alone caused significant depletion of NADH but no cell death; combined treatment with CysNO led to morphological changes, increased LDH release, accumulation of S-nitrosothiols, depletion of ATP and NAD+, and triggered cell death. PMC3757685
IMR90-E1A cells 100 µM 24 hours Validate the role of GSK3β in DMNQ-dependent necrotic response, cell death was significantly reduced after GSK3β silencing PMC6952365
U87MG cells 30 µM 24 hours Study of DMNQ-induced necrotic death, GSK3β absence significantly reduced cell death PMC6952365
Human femoral and talar chondrocytes 25 μM 0-60 minutes To investigate the effect of DMNQ on MAP kinase signaling pathways, results showed that DMNQ treatment led to enhanced phosphorylation of ERK, p38, JNK, and c-Jun, with similar responses in femoral and talar chondrocytes. PMC6530906
Human articular chondrocytes 25 μM 60 min To investigate the effect of DMNQ on hyperoxidation of Prx1 and Prx2, results showed DMNQ induced hyperoxidation of Prx1 and Prx2 but not Prx3. PMC6588440
Rat embryonic neural stem cells 3 μM 8 hours To evaluate the effects of DMNQ-induced oxidative stress on neural stem cells, results showed that DMNQ exposure led to increased ROS production and increased apoptosis. PMC3032322
Lymphocytes 1, 3, and 5μM 30 minutes To assess the impact of DMNQ on lymphocyte bioenergetics, results showed that DMNQ modulated lymphocyte metabolism in a dose-dependent manner, suppressing basal, PMA-sensitive, and oligomycin-sensitive changes in OCR and ECAR. PMC5611861
Bovine aortic endothelial cells (BAEC) 15 µM 1 hour To investigate the effect of DMNQ on mitochondrial function, it was found that DMNQ increased the basal oxygen consumption rate (OCR) and decreased the maximal OCR and reserve capacity. PMC2860730

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.58mL

0.92mL

0.46mL

22.91mL

4.58mL

2.29mL

45.83mL

9.17mL

4.58mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories